CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value

CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value

Chosen cutoff for cytokeratin 19 fragment antigen (CYFRA 21-1) as a tumor biomarker considerably influences its diagnostic and prognostic usefulness. The aim of the present study is to determine an optimal cutoff value for diagnostic validity of CYFRA 21-1 by Lumipulse ® technology in patients with...

Full description

Bibliographic Details
Main Authors: Garcia-Valdecasas Gayo Sonsoles, Ruiz-Alvarez Maria Jesus, Gonzalez-Gay Daniel, Ramos-Corral Raquel, Marquez-Lietor Eva, Del Amo Nazaret, Plata Maria del Carmen, Guillén-Santos Raquel, Arribas Ignacio, Cava-Valenciano Fernando
Format: Article
Language:English
Published: De Gruyter 2020-10-01
Series:Advances in Laboratory Medicine
Subjects:
bladder cancer
cutoff
cyfra 21-1
lung cancer
non-small cell lung cancer (nsclc)
prognosis
tumor marker
Online Access:https://doi.org/10.1515/almed-2020-0005

Internet

https://doi.org/10.1515/almed-2020-0005

Similar Items